An Up to Two-Part Relative Bioavailability Study of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets as Compared to the Reference Phase 2 Ad Hoc Combination Tablets in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Jun 2016
At a glance
- Drugs Danoprevir/ritonavir (Primary) ; Danoprevir; Ritonavir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Roche
- 03 Feb 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2012 Planned End Date changed from 1 Jul 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
- 21 May 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.